FindTrial
Sign In

Prognostic Observation in Patients with Cutaneous Adverse Reactions Induced by Antineoplastic Drugs

Prognostic Observation in Patients with Cutaneous Adverse Reactions Induced by Antineoplastic Drugs

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111255
Enrollment
Unknown
Registered
2025-10-28
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cutaneous Adverse Reaction

Interventions

Observation group:This study was observational and did not involve any interventions.

Sponsors

Dermatology Hospital, Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 100 Years

Inclusion criteria

Inclusion criteria: (1) The subject has provided written informed consent and voluntarily participates in this study. (2) Patients who have developed cutaneous adverse reactions following anticancer drug therapy. (3) The cutaneous adverse reactions have not been treated with systemic immunosuppressive agents, such as corticosteroids. (4) The subject has a life expectancy of >1 year.

Exclusion criteria

Exclusion criteria: Circumstances deemed by the investigator as unsuitable for study inclusion.

Design outcomes

Primary

MeasureTime frame
Distribution of drAE Types;—

Secondary

MeasureTime frame
Overall Survival;Progression-Free Survival;Time to Rash Resolution;Time to Recovery from Severe Adverse Reactions;Change in Quality of Life;—

Countries

China

Contacts

Public ContactGuannan Zhu

Dermatology Hospital, Southern Medical University

zhuguannan@smu.edu.cn+86 20 8302 7560

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026